OROS-methylphenidate to reduce ADHD symptoms in male prisoners aged 16 25 years: a RCT
Article in Efficacy and Mechanism Evaluation (June 2022)
The most recent citing publications are shown below. View all 14 publications that cite this research output on Dimensions.
Article in Efficacy and Mechanism Evaluation (June 2022)
Article in Journal of Personality Disorders (June 2022)
Article in Nutrients (April 2022)